Previous 10 | Next 10 |
Published Recently in the Journal of the American Academy of Dermatology Castle Biosciences, Inc. (Nasdaq: CSTL), a skin cancer diagnostics company providing personalized genomic information to improve cancer treatment decisions, today announced the publication of a systematic review a...
Results of the March 25-26, 2020, Independent Study will be Hosted on Castle’s Website Castle Biosciences, Inc. (Nasdaq: CSTL), a skin and eye cancer diagnostics company providing personalized genomic information to improve cancer treatment decisions, today posted to its website...
Image source: The Motley Fool. Castle Biosciences Inc (NASDAQ: CSTL) Q4 2019 Earnings Call Mar 10, 2020 , 4:30 p.m. ET Operator Continue reading
The following slide deck was published by Castle Biosciences, Inc. in conjunction with their 2019 Q4 earnings Read more ...
Castle Biosciences, Inc. (CSTL) Q4 2019 Earnings Conference Call March 10, 2020 16:30 ET Corporate Participants Frank Stokes - Chief Financial Officer Derek Maetzold - President, and Chief Executive Officer Conference Call participants Puneet Souda - SVB Leerink Sung Ji Nam...
Castle Biosciences (NASDAQ: CSTL ): Q4 GAAP EPS of $0.11 beats by $0.31 . More news on: Castle Biosciences, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
Q4 2019 recognized revenues of $17.6 million, compared to $11.4 million in Q4 2018 Q4 2019 adjusted revenues of $17.6 million, compared to $6.2 million in Q4 2018 Full-year 2019 revenues of $51.9 million, compared to $22.8 million in 2018 Full-year 2019 gross margin was 86% 2020 revenue...
Castle Biosciences, Inc. (Nasdaq: CSTL), a skin cancer diagnostics company providing personalized genomic information to improve cancer treatment decisions, today announced that it will release its financial results for the fourth quarter and year-ended December 31, 2019, after the close of m...
Castle Biosciences, Inc. (Nasdaq: CSTL), a skin cancer diagnostics company providing personalized genomic information to improve cancer treatment decisions, today announced that Derek Maetzold, president and chief executive officer, is scheduled to present a company overview at the 9 th Annu...
Data presented at the 2020 Winter Clinical Dermatology Conference Castle Biosciences, Inc. (Nasdaq: CSTL), a skin cancer diagnostics company providing personalized genomic information to improve cancer treatment decisions, today announced the presentation of clinical utility data for i...
News, Short Squeeze, Breakout and More Instantly...
Castle Biosciences Inc. Company Name:
CSTL Stock Symbol:
NASDAQ Market:
Castle Biosciences Inc. Website:
Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that its executive management is scheduled to present a company overview at the Canaccord Genuity 44 th Annual Growth Conference on Tuesday, Aug. 13, 2024, at ...
Campaign will focus on empowering patients impacted by melanoma Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, has joined forces with television personality, wellness coach and founder of ALL IN by Teddi, host of the...
Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that it will release its financial results for the second quarter and six months ended June 30, 2024, after the close of market on Monday, Aug. 5, 2024. Compan...